Description
Lazolvan Tablets 30 mg. №20
Composition
Active ingredient: Ambroxol hydrochloride 30 mg per tablet.
Mechanism of Action
Ambroxol, as the active ingredient in Lazolvan tablets, acts as a mucolytic agent by reducing the viscosity of mucus in the respiratory tract. This mechanism helps in easier expectoration and clearance of airways, facilitating improved breathing.
Pharmacological Properties
Ambroxol hydrochloride in Lazolvan tablets exhibits mucolytic, expectorant, and bronchodilator properties. It enhances mucus clearance, reduces cough frequency, and aids in improving lung function in respiratory conditions.
Indications for Use
Lazolvan tablets 30 mg. №20 are indicated for respiratory conditions characterized by excessive mucus production, including acute and chronic bronchitis, bronchiectasis, and asthma. The tablets help in clearing mucus and improving breathing.
Contraindications
Do not use Lazolvan tablets 30 mg. №20 if:
- You are allergic to Ambroxol or any other tablet ingredients.
- You have a history of hypersensitivity reactions to mucolytic agents.
- You are in the first trimester of pregnancy.
Side Effects
Common side effects of Lazolvan tablets may include gastrointestinal disturbances, such as nausea and vomiting, as well as allergic reactions like skin rashes. In rare cases, hypersensitivity reactions may occur, warranting immediate medical attention.
Usage Instructions
Dosage: Take 1 tablet orally three times a day. Swallow the tablet whole with water, with or without food, as directed by your healthcare provider. Avoid exceeding the recommended dose to prevent adverse effects.
Benefits Compared to Analogues
Lazolvan tablets offer a distinct advantage over other mucolytic agents due to the proven efficacy of Ambroxol in improving mucus clearance, reducing cough frequency, and enhancing respiratory function. The targeted action of Lazolvan tablets makes them a preferred choice in managing respiratory conditions.
Suitable Patient Groups
Lazolvan tablets are suitable for adults, adolescents, and elderly patients with respiratory conditions requiring mucolytic therapy. However, caution is advised in pregnant women, especially during the first trimester, and individuals with a history of hypersensitivity reactions to similar agents.
Storage and Shelf Life
Store Lazolvan tablets in a cool, dry place away from direct sunlight. Keep the tablets in their original packaging to protect them from moisture. Check the expiration date on the packaging and do not use the tablets beyond the specified shelf life.
Packaging Description
Lazolvan tablets 30 mg. №20 are packaged in blister packs to ensure individual tablet integrity and ease of dispensing. The packaging is designed to maintain the quality and stability of the tablets throughout their shelf life.
